Intravenous posaconazole: key features of clinical pharmacology and practical applications
Invasive fungal infections in various categories of patients remain one of the most urgent problems of modern medicine. This is complicated by the imperfection of diagnostic methods, as well as a small range of antimycotics for systemic use. The market launch in 2005 of posaconazole, a second-genera...
Main Authors: | A. V. Veselov, N. N. Klimko |
---|---|
Format: | Article |
Language: | Russian |
Published: |
ABV-press
2022-04-01
|
Series: | Онкогематология |
Subjects: | |
Online Access: | https://oncohematology.abvpress.ru/ongm/article/view/544 |
Similar Items
-
New Drug Formulations of Posaconazole: Brief Clinical Pharmacology Review
by: Veselov A.V.
Published: (2016-11-01) -
The tablet formulation of posaconazole: clinical pharmacology and the use in patients with hematologic malignancies
by: Veselov A.V.
Published: (2020-05-01) -
The Outcome of Antifungal Prophylaxis with Posaconazole in Patients with Acute Myeloid Leukemia: A Single-Center Study
by: Vildan Özkocaman, et al.
Published: (2018-11-01) -
Dose Optimisation of Posaconazole and Therapeutic Drug Monitoring in Pediatric Patients
by: Mengmeng Jia, et al.
Published: (2022-04-01) -
Deciphering the Relationship Between the Trough Concentration of Posaconazole and Its Efficacy and Safety in Chinese Patients With Hematological Disorders
by: Meng-Meng Jia, et al.
Published: (2020-10-01)